Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
CALL
Howard Hughes
HHH
$3.87B
| $2.38M | ﹤0.01% |
21,819
-13,847
| -39% | -$1.54M |
|
3252
Cheniere Energy
CQP
$33.4B
| $2.38M | ﹤0.01% |
+81,369
| New | +$2.26M |
|
|
UTLF
3253
DELISTED
iShares Edge MSCI Multifactor Utilities ETF
UTLF
| $2.38M | ﹤0.01% |
94,417
-5,078
| -5% | -$132K |
|
|
FDC
3254
CALL
DELISTED
First Data Corporation
FDC
| $2.38M | ﹤0.01% |
180,800
+40,900
| +29% | +$527K |
|
3255
CALL
Strategy Inc
MSTR
$50.6B
| $2.38M | ﹤0.01% |
142,000
-855,000
| -86% | -$14.7M |
|
3256
CALL
CoreCivic
CXW
$3.34B
| $2.37M | ﹤0.01% |
171,100
+147,200
| +616% | +$3.51M |
|
|
ENV
3257
CALL
DELISTED
ENVESTNET, INC.
ENV
| $2.37M | ﹤0.01% |
65,100
+32,500
| +100% | +$1.23M |
|
3258
PUT
iShares Russell 3000 ETF
IWV
$20.3B
| $2.37M | ﹤0.01% |
18,500
+2,800
| +18% | +$358K |
|
|
LNKD
3259
DELISTED
LinkedIn Corporation
LNKD
| $2.37M | ﹤0.01% |
12,411
-37,094
| -75% | -$7.11M |
|
3260
PUT
AngloGold Ashanti
AU
$57.2B
| $2.37M | ﹤0.01% |
148,900
+2,100
| +1% | +$39.9K |
|
3261
CALL
Brookfield
BN
$92.3B
| $2.36M | ﹤0.01% |
188,344
+103,982
| +123% | +$1.27M |
|
|
PIV
3262
DELISTED
PWSHS S&P 500 HIGH QTY PORTF S&P HIGH QTY RKGS INDEX
PIV
| $2.36M | ﹤0.01% |
93,852
+8,973
| +11% | +$226K |
|
|
IBDQ
3263
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
| $2.36M | ﹤0.01% |
+92,238
| New | +$2.36M |
|
|
ZOES
3264
CALL
DELISTED
Zoe's Kitchen, Inc.
ZOES
| $2.36M | ﹤0.01% |
106,300
-38,700
| -27% | -$1.23M |
|
3265
CALL
iShares Russell 2000 Value ETF
IWN
$14.5B
| $2.36M | ﹤0.01% |
22,500
+12,500
| +125% | +$1.28M |
|
3266
PACCAR
PCAR
$66B
| $2.36M | ﹤0.01% |
60,150
| – | – |
|
3267
CALL
Everest Group
EG
$14.5B
| $2.36M | ﹤0.01% |
12,400
-4,100
| -25% | -$771K |
|
|
CVGW
3268
CALL
DELISTED
Calavo Growers
CVGW
| $2.35M | ﹤0.01% |
36,000
+28,000
| +350% | +$1.82M |
|
3269
PUT
Enovis
ENOV
$1.44B
| $2.35M | ﹤0.01% |
43,517
-3,254
| -7% | -$164K |
|
3270
CALL
Bank of Hawaii
BOH
$3.05B
| $2.35M | ﹤0.01% |
32,400
+15,600
| +93% | +$1.09M |
|
3271
PUT
iShares MSCI South Africa ETF
EZA
$587M
| $2.35M | ﹤0.01% |
41,900
+2,000
| +5% | +$112K |
|
3272
First Trust Mid Cap Core AlphaDEX Fund
FNX
$1.39B
| $2.35M | ﹤0.01% |
44,570
+38,582
| +644% | +$2.02M |
|
3273
Hubbell
HUBB
$24.3B
| $2.35M | ﹤0.01% |
21,800
| – | – |
|
3274
CALL
Tower Semiconductor
TSEM
$23.5B
| $2.34M | ﹤0.01% |
154,400
-56,200
| -27% | -$812K |
|
|
KERX
3275
PUT
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $2.34M | ﹤0.01% |
441,000
+196,400
| +80% | +$1.06M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.